Chronic treatment with a glucagon receptor antagonist lowers glucose and moderately raises circulating glucagon and glucagon-like peptide 1 without severe alpha cell hypertrophy in diet-induced obese mice-Reference-Cited by-同舟云学术

Chronic treatment with a glucagon receptor antagonist lowers glucose and moderately raises circulating glucagon and glucagon-like peptide 1 without severe alpha cell hypertrophy in diet-induced obese mice

Published:2011-06-22 Issue:9 Volume:54 Page:2381-2391
ISSN:0012-186X
Container-title:Diabetologia
language:en
Short-container-title:Diabetologia

Author:

Mu J.,Jiang G.,Brady E.,Dallas-Yang Q.,Liu F.,Woods J.,Zycband E.,Wright M.,Li Z.,Lu K.,Zhu L.,Shen X.,SinhaRoy R.,Candelore M. L.,Qureshi S. A.,Shen D-M.,Zhang F.,Parmee E. R.,Zhang B. B.

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00125-011-2217-2.pdf

Reference32 articles.

1. Unger RH (1971) Glucagon physiology and pathophysiology. N Engl J Med 285:443–449

2. Fanelli CG, Porcellati F, Rossetti P, Bolli GB (2006) Glucagon: the effects of its excess and deficiency on insulin action. Nutr Metab Cardiovasc Dis 16(Suppl 1):S28–S34

3. Jiang G, Zhang BB (2003) Glucagon and regulation of glucose metabolism. Am J Physiol Endocrinol Metab 284:E671–E678

4. Burcelin R, Katz EB, Charron MJ (1996) Molecular and cellular aspects of the glucagon receptor: role in diabetes and metabolism. Diabetes Metab 22:373–396

5. Toft I, Gerich JE, Jenssen T (2002) Autoregulation of endogenous glucose production during hyperglucagonemia. Metabolism 51:1128–1134

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The glucagon-receptor antagonist MK-3577 reduces glucagon-stimulated plasma glucose and insulin concentrations in metabolically healthy overweight cats;Domestic Animal Endocrinology;2024-10

2. The impact of glucagon to support postabsorptive glucose flux and glycemia in healthy rats and its attenuation in male Zucker diabetic fatty rats;American Journal of Physiology-Endocrinology and Metabolism;2024-03-01

3. Blockade of glucagon increases muscle mass and alters fiber type composition in mice deficient in proglucagon‐derived peptides;Journal of Diabetes Investigation;2023-06-09

4. Sustained glucagon receptor antagonism in insulin-deficient high-fat-fed mice;Journal of Endocrinology;2022-11-01

5. The past, present, and future physiology and pharmacology of glucagon;Cell Metabolism;2022-11